Clinical Trials Browser

INDUSTRY × Triple Negative Breast Neoplasms × CUDC-907 × Clear all

NCT02307240 2019-09-03

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Phase 1 Completed

Triple Negative Breast Neoplasms